India's pharmaceutical industry is evolving as healthcare needs, treatment patterns and medicine consumption continue to change. From cardiac and diabetes care to dermatology and oncology, different therapeutic segments are creating opportunities across the pharmaceutical value chain.

For pharmaceutical manufacturers, distributors, wholesalers and retailers, understanding these segments is important for identifying market demand, evaluating product portfolios and making informed business decisions.

But which therapeutic segments are leading India's pharmaceutical market in 2026?

Let's explore the 10 major segments, their market position and the trends shaping their growth.

Understanding India's Therapeutic Segments

A therapeutic segment refers to a category of medicines used to treat a particular disease, condition or group of health problems.

For example:

Cardiac medicines are used for cardiovascular conditions.

Anti-diabetic medicines support diabetes management.

Gastrointestinal medicines address digestive disorders.

Dermatology medicines are used for skin-related conditions.

These categories help pharmaceutical businesses understand the market, organise their product portfolios and identify areas of demand.

Top 10 Therapeutic Segments in India

The following ranking uses the Department of Pharmaceuticals' FY 2024–25 domestic sales data as the market-size baseline. Recent 2026 performance trends are discussed separately, so historical market size is not confused with current growth.

1. Cardiac Segment

The cardiac segment is one of the largest therapeutic categories in India's pharmaceutical market.

It includes medicines used to manage:

Hypertension

High cholesterol

Heart failure

Coronary artery disease

Other cardiovascular conditions

India's growing burden of cardiovascular risk factors continues to make this an important area of long-term treatment.

Business perspective: Cardiac medicines represent an important category for pharmaceutical distributors because many treatments involve regular, long-term prescriptions.

2. Gastrointestinal Segment

The gastrointestinal segment covers medicines used to manage digestive and stomach-related conditions.

Major categories include:

Acidity and acid reflux treatments

Ulcer management medicines

Antacids

Digestive health medicines

Medicines for certain intestinal conditions

Demand comes from a wide range of healthcare settings, including general physicians, gastroenterologists, hospitals and retail pharmacies.

Business perspective: This segment offers a broad product category for businesses serving general medicine and specialist prescription markets.

3. Anti-Infective Segment

Anti-infective medicines are used to prevent or treat infections caused by microorganisms.

This category includes:

Antibiotics

Antifungal medicines

Antiviral medicines

Antiparasitic medicines

Anti-infectives remain a major part of India's pharmaceutical market. However, responsible antibiotic use and antimicrobial resistance are important considerations for the industry.

Business perspective: Product availability, appropriate storage and responsible distribution are important when handling anti-infective medicines.

4. Anti-Diabetic Segment

Diabetes management is an important part of India's healthcare landscape.

The segment includes:

Oral anti-diabetic medicines

Insulin preparations

Combination therapies

Newer glucose-lowering treatments

The growing focus on diabetes diagnosis and long-term disease management is influencing the development of this market.

Business perspective: The segment offers opportunities for businesses supplying chronic-care medicines and supporting consistent product availability.

5. Vitamins, Minerals and Nutrients (VMN)

The VMN segment includes products designed to address nutritional deficiencies and support specific nutritional requirements.

It covers:

Multivitamins

Iron supplements

Calcium supplements

Vitamin D preparations

Other vitamins and mineral formulations

Increasing awareness of nutrition and preventive healthcare is contributing to interest in this category.

Business perspective: VMN products serve multiple consumer and healthcare channels, making this a relevant category for businesses with a diversified pharmaceutical portfolio.

6. Respiratory Segment

Respiratory medicines are used to manage conditions affecting the lungs and airways.

Common categories include:

Bronchodilators

Anti-asthmatic medicines

Cough and cold preparations

Medicines used in COPD management

Other respiratory treatments

Demand in this segment can be influenced by seasonal infections, air quality, weather conditions and the prevalence of chronic respiratory diseases.

Business perspective: Distributors may need to consider seasonal demand variations while planning their respiratory product portfolio.

7. Pain and Analgesics Segment

Pain-management medicines are used across several healthcare settings.

This category includes:

Analgesics

Anti-inflammatory medicines

Medicines for musculoskeletal pain

Certain combination pain-relief formulations

These products are used in the management of different types of pain, depending on the medicine and clinical indication.

Business perspective: The segment has applications across general practice, orthopaedics, dentistry and other healthcare specialties.

8. Neurology and CNS Segment

The neurology and central nervous system segment includes medicines used to manage conditions affecting the brain, nerves and nervous system.

It covers treatments for:

Epilepsy

Parkinson's disease

Certain neurological disorders

Selected psychiatric conditions

Other central nervous system conditions

As diagnosis and treatment of neurological conditions receive greater attention, this segment remains an important part of the pharmaceutical market.

Business perspective: This category includes specialised prescription products and requires careful attention to applicable prescription and distribution requirements.

9. Dermatology Segment

The dermatology segment focuses on medicines and formulations used for skin-related conditions.

It includes:

Antifungal preparations

Acne treatments

Topical corticosteroids

Antibacterial skin preparations

Other dermatological formulations

Growing attention to skin health and the availability of specialised treatments have helped make dermatology an important pharmaceutical category.

Business perspective: Dermatology provides opportunities across topical formulations, prescription products and selected consumer healthcare categories.

10. Gynaecology Segment

The gynaecology segment includes medicines used in women's reproductive and hormonal health.

It covers products related to:

Menstrual health

Hormonal conditions

Reproductive healthcare

Certain gynaecological infections

Other women's healthcare requirements

Greater attention to women's healthcare and access to specialised treatments make this a relevant therapeutic category.

Business perspective: Businesses serving gynaecologists, hospitals and retail pharmacies may consider this segment when evaluating their product mix.

Which Therapeutic Segments Are Showing Strong Growth in 2026?

Market size and market growth are two different measures. A large therapeutic segment is not necessarily the fastest-growing one.

Recent September 2026 market tracking reported strong year-on-year growth across several categories, including vitamins, minerals and nutrients, anti-diabetic and cardiac therapies. Neurology, gastrointestinal, dermatology and pain-related categories also recorded notable growth.

Respiratory and anti-infective segments showed comparatively slower growth in the same reporting period.

This suggests that India's pharmaceutical market is seeing opportunities across both established treatment categories and evolving healthcare needs.

What Do These Trends Mean for Pharmaceutical Distributors?

Understanding therapeutic segments can help pharmaceutical distributors make more informed business decisions.

1. Evaluate Product Demand

Study the healthcare needs and prescription patterns in the markets you serve before expanding your product portfolio.

2. Build a Balanced Portfolio

Depending on your business model, consider a mix of established therapeutic categories and specialised products rather than relying on a single segment.

3. Understand Chronic and Acute Therapy Requirements

Chronic-care medicines often require consistent availability, while acute-care categories can experience seasonal changes in demand.

4. Work with Reliable Pharmaceutical Suppliers

A dependable supply partner, consistent product availability and transparent business communication can support smoother distribution operations.

5. Monitor Changing Market Trends

Regularly review market developments, product demand and regulatory requirements to keep your business aligned with changing industry conditions.

How Agrosaf Supports Pharmaceutical Businesses

Selecting the right product portfolio is an important part of building a sustainable pharmaceutical distribution business.

Agrosaf Pharmaceuticals supports B2B pharmaceutical businesses through its product portfolio and business sourcing platform, helping buyers explore pharmaceutical products for their business requirements.

Explore the Agrosaf B2B platform to discover its pharmaceutical product range.

Conclusion

The Indian pharmaceutical market includes a wide range of therapeutic segments, each serving different healthcare needs and business opportunities.

Cardiac, gastrointestinal, anti-infective, anti-diabetic and nutritional categories represent major parts of the domestic market, while dermatology, neurology, gynaecology and other specialised segments continue to contribute to its diversity.

For pharmaceutical distributors and wholesalers, understanding these categories is not just about following market trends. It is about making better product-selection decisions, understanding customer requirements and building a balanced business portfolio.

As India's healthcare needs evolve, staying informed about therapeutic segments can help pharmaceutical businesses make more strategic decisions.

Frequently Asked Questions

1. What are the major therapeutic segments in the Indian pharma market?

Major segments include cardiac, gastrointestinal, anti-infective, anti-diabetic, vitamins and minerals, respiratory, pain management, neurology, dermatology and gynaecology.

2. Which is the largest therapeutic segment in India?

According to the Department of Pharmaceuticals' FY 2024–25 domestic sales data, cardiac was the largest therapeutic segment by sales value.

3. Which therapeutic segments are growing in 2026?

Recent market reports have highlighted growth in vitamins, minerals and nutrients, anti-diabetic, cardiac, dermatology, pain and several other therapy categories. Growth rates vary by reporting period and data source.

4. Why should pharmaceutical distributors understand therapeutic segments?

Understanding therapeutic segments helps distributors assess demand, identify relevant product categories and make better portfolio and sourcing decisions.

5. What is the difference between acute and chronic therapeutic segments?

Acute therapies generally address short-term health conditions, while chronic therapies are used to manage long-term conditions that may require ongoing treatment.